Related Experiment Videos
[The effect of dactinomycin on retinal injury induced by argon laser in mouse]
Objective:
To determine that the administration of RNA synthesis inhibitor (dactinomycin) prevents retinal photoreceptor cell injury induced by green wavelength of argon laser in SD mice.
Methods:
At various time (0, 8, 20 h) after the exposure to laser, eyes of the mice were injected intraocularly with dactinomycin in experimental eyes, and saline in control ones, and the concentration of the drug were 10 g/L, 5 g/L, 2.5 g/L. The eyes were taken at 24 h after the exposure, the slices of the retina were stained with methyl green-pyronin (MG-P), and pyknotic (violet) as well as surviving cells (green) were counted in the laser burns.
Results:
Intraocular administration of dactinomycin diminished the degeneration induced by argon laser, there were marked differences between the experimental group and the control group, dactinomycin showed to be more effective if administered immediately after exposure and 8 h later, after this time the higher concentration of the drug could not result in higher effect.
Conclusion:
Dactinomycin can inhibit the occurrence of the laser injury, but the time selected for the administration is critical for its efficacy.
Insights
Dactinomycin prevents retinal photoreceptor cell damage from argon laser exposure in mice. Immediate or 8-hour post-exposure administration is most effective for this RNA synthesis inhibitor.
Area of Science:
- Ophthalmology
- Pharmacology
- Cell Biology
Context:
- Argon laser exposure can cause retinal photoreceptor cell injury.
- RNA synthesis inhibitors may offer protective effects against cellular damage.
Purpose:
- To investigate the efficacy of dactinomycin, an RNA synthesis inhibitor, in preventing argon laser-induced retinal photoreceptor cell injury in Sprague Dawley (SD) mice.
Summary:
- Dactinomycin was administered intraocularly to mice at varying times (0, 8, 20 hours) after argon laser exposure.
- Retinal cell survival was assessed 24 hours post-exposure using methyl green-pyronin staining.
- Intraocular dactinomycin significantly reduced laser-induced retinal degeneration, with optimal protection observed when administered immediately or 8 hours post-exposure.
Impact:
- Dactinomycin demonstrates potential as a therapeutic agent to mitigate laser-induced retinal damage.
- The timing of dactinomycin administration is crucial for maximizing its protective effects against retinal injury.